Genscript Biotech Corporation
Genscript Biotech Corporation (GNNSF) Stock Overview
Explore Genscript Biotech Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.1B
P/E Ratio
-5.84
EPS (TTM)
$-0.25
ROE
-0.13%
GNNSF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Genscript Biotech Corporation (GNNSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 34.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.86.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.84 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.